Comparative study of adjuvants for allergen-specific immunotherapy in a murine model

被引：12
作者：
Vazquez de la Torre, Maria [1 ]
Luisa Baeza, Maria [2 ,3 ,4 ]
Najera, Laura [5 ]
Manuel Zubeldia, Jose [2 ,3 ,4 ]
机构：
[1] Infanta Leonor Univ Hosp, Allergy Serv, Madrid, Spain
[2] Gregorio Maranon Univ Gen Hosp, Allergy Serv, Madrid, Spain
[3] Biomed Res Network Rare Dis CIBERER U761, Madrid, Spain
[4] Gregorio Maranon Hlth Res Inst, Madrid, Spain
[5] Puerta Hierro Majadahonda Univ Hosp, Patol Serv, Madrid, Spain
来源：
IMMUNOTHERAPY | 2018年 / 10卷 / 14期
关键词：
adjuvants; allergen-specific immunotherapy; allergic asthma; aluminum hydroxide; calcium phosphate; immunostimulatory sequences; monophosphoryl lipid A; murine model; INDUCED AIRWAY INFLAMMATION; IGE ANTIBODY-FORMATION; CPG OLIGODEOXYNUCLEOTIDES; IMMUNE-RESPONSE; IMMUNOSTIMULATORY DNA; EXPERIMENTAL ASTHMA; TH1; RESPONSES; MICE; HYPERRESPONSIVENESS; INDUCTION;
D O I：
10.2217/imt-2018-0072
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Aim: To compare the immunological and clinical changes induced by allergen-specific immunotherapy (AIT) using different adjuvants. Materials & methods:Olea europaea pollen-sensitized mice were treated with olea plus aluminum hydroxide, calcium phosphate, monophosphoryl lipid A (MPL) or immunostimulatory sequences (ISS). Results: Aluminum hydroxide seems to drive initially to a Th2-type response. Bacteria-derived adjuvants (MPL and ISS) skew the immune response toward Th1 and Treg pathways. Specific-IgE production was lower after AIT with MPL and ISS. Moreover, IgG2a production significantly increased in ISS-treated mice. Bacteria-derived adjuvants also improved the Th1 cytokine response due to IFN- higher secretion. In addition, they improved bronchial hyper-reactivity and lung inflammation. Conclusion: Bacteria-derived adjuvants may enhance the efficacy of AIT.
引用
收藏
页码：1219 / 1228
页数：10
相关论文
共 42 条
  • [1] Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
    Akdis, Cezmi A.
    Akdis, Muebeccel
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2015, 8
  • [2] Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice
    Alignani, D
    Maletto, B
    Liscovsky, M
    Rópolo, A
    Morón, G
    Pistoresi-Palencia, MC
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 77 (06) : 898 - 905
  • [3] CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung
    Ashino, Shigeru
    Wakita, Daiko
    Zhang, Yue
    Chamoto, Kenji
    Kitamura, Hidemitsu
    Nishimura, Takashi
    [J]. INTERNATIONAL IMMUNOLOGY, 2008, 20 (02) : 259 - 266
  • [4] Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report
    Burks, A. Wesley
    Calderon, Moises A.
    Casale, Thomas
    Cox, Linda
    Demoly, Pascal
    Jutel, Marek
    Nelson, Harold
    Akdis, Cezmi A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (05) : 1288 - U65
  • [5] Immunotherapy: What lies beyond
    Casale, Thomas B.
    Stokes, Jeffrey R.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (03) : 612 - 619
  • [6] The active contribution of Toll-like receptors to allergic airway inflammation
    Chen, Keqiang
    Xiang, Yi
    Yao, Xiaohong
    Liu, Ying
    Gong, Wanghua
    Yoshimura, Teizo
    Wang, Ji Ming
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (10) : 1391 - 1398
  • [7] Pollen-induced airway inflammation, hyper-responsiveness and apoptosis in a murine model of allergy
    Conejero, L.
    Higaki, Y.
    Baeza, M. L.
    Fernandez, M.
    Varela-Nieto, I.
    Zubeldia, J. M.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (03) : 331 - 338
  • [8] Comparison of adjuvant and adjuvant-free murine experimental asthma models
    Conrad, M. L.
    Yildirim, A. Oe.
    Sonar, S. S.
    Kilic, A.
    Sudowe, S.
    Lunow, M.
    Teich, R.
    Renz, H.
    Garn, H.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (08) : 1246 - 1254
  • [9] The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells
    De Becker, G
    Moulin, V
    Pajak, B
    Bruck, C
    Francotte, M
    Thiriart, C
    Urbain, J
    Moser, M
    [J]. INTERNATIONAL IMMUNOLOGY, 2000, 12 (06) : 807 - 815
  • [10] Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis
    Dhami, S.
    Kakourou, A.
    Asamoah, F.
    Agache, I.
    Lau, S.
    Jutel, M.
    Muraro, A.
    Roberts, G.
    Akdis, C. A.
    Bonini, M.
    Cavkaytar, O.
    Flood, B.
    Gajdanowicz, P.
    Izuhara, K.
    Kalayci, O.
    Mosges, R.
    Palomares, O.
    Pfaar, O.
    Smolinska, S.
    Sokolowska, M.
    Asaria, M.
    Netuveli, G.
    Zaman, H.
    Akhlaq, A.
    Sheikh, A.
    [J]. ALLERGY, 2017, 72 (12) : 1825 - 1848
12345